Condition: Intracardiac Thrombus · Sponsor: Azienda Ospedaliero, Universitaria Ospedali Riuniti
The goal of this observational study is to determine the efficacy of rivaroxaban treatment for intracardiac thrombi resolution in pediatric patients (\< 16 years old) diagnosed with intracardiac thrombosis. The main question it aims to answer is: Does rivaroxaban treatment resolve the thrombosis during a 3-month treatment? Participants already taking rivaroxaban as part of their regular medical care for thrombosis resolution. They will undergo monthly visits to check that the treatment is progressing correctly and that no major bleeding has occurred. After 3 months of treatment, they will repeat the radiological imaging investigation to verify the actual resolution of the thrombosis.
This description comes directly from the study's public registry record.
Francesco Bianco, M.D., Ph.D. · +39 071 5965283 · francesco.bianco@ospedaliriuniti.marche.it
Valentina Bucciarelli, M.D., Ph.D. · +39 071 5965283 · valentina.bucciarelli@ospedaliriuniti.it
Always discuss trial participation with your own doctor first.
| CCPC | Ancona, The Marches, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06371170